Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Orexigen Therapeutics, Inc.
(NQ:
OREX
)
6.040
USD
-0.010 (-0.17%)
Official Closing Price
/ Updated:
4:00 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
6.100
Bid (Size)
6.030 (51800)
Ask (Size)
6.040 (15800)
Prev. Close
6.050
Today's Range
6.010 - 6.120
52wk Range
3.100 - 7.730
Shares Outstanding
94,642,128
Dividend Yield
N/A
Top News
More News
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
May 17, 2013
from
PR Newswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 13, 2013
from
Business Wire News Releases
More News
Read More
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
category
TOKYO:ESALY
,
NASDAQ:OREX
,
NASDAQ:ARNA
, and 1 more.
from
Forbes Real Time
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from
PR Newswire
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
May 08, 2013
from
PR Newswire
Will The Prescription Diet Pill Market Finally Bulk Up?
May 08, 2013
category
NASDAQ:OREX
,
NASDAQ:ARNA
,
NASDAQ:VVUS
from
Forbes Real Time
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 07, 2013
from
PR Newswire
MDT, HLF, OREX, and NVS Early Briefing and Review
May 06, 2013
from
ACCESSWIRE
VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
May 03, 2013
from
StreetInsider.com News Articles
Arena Withdraws Application for Weight-Loss Drug Approval in Europe
May 03, 2013
category
orex
,
vvus
,
arna
from
DailyFinance.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.